PubRank

D K Chopin

Author PubWeight™ 45.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 1996 1.85
2 Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment. BJU Int 2001 1.56
3 Laparoscopic radical prostatectomy: preliminary results. Urology 2000 1.42
4 Retroperitoneal laparoscopy of a retrocaval ureter. BJU Int 1999 1.17
5 BCG intravesical instillations: recommendations for side-effects management. Eur Urol 2000 1.14
6 Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 2002 1.05
7 Retroperitoneal laparoscopic versus open radical nephrectomy. J Urol 1999 1.05
8 Laparoscopic promontory sacral colpopexy: is the posterior, recto-vaginal, mesh mandatory? Eur Urol 2004 1.05
9 The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse. J Anat 2001 1.02
10 Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer. Hum Pathol 1998 0.96
11 Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review. Urol Res 1998 0.96
12 Magnetic resonance imaging of penile rupture: aid to diagnosis. J Urol 1995 0.93
13 Partial nephrectomy with retroperitoneal laparoscopy. J Urol 1999 0.93
14 Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br J Cancer 2000 0.92
15 Laparoscopic radical prostatectomy: preliminary results. Eur Urol 2000 0.90
16 Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma. Urol Res 1992 0.90
17 Laparoscopic adrenalectomy: the retroperitoneal approach. J Urol 1998 0.89
18 The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 1997 0.89
19 Symptomatic caliceal diverticula treated with extraperitoneal laparoscopic marsupialization fulguration and gelatin resorcinol formaldehyde glue obliteration. J Urol 1998 0.89
20 Relationship between penile thermal sensory threshold measurement and electrophysiologic tests to assess neurogenic impotence. Urology 2001 0.89
21 T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer. J Urol 2001 0.87
22 Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer. Urology 2001 0.87
23 Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells. Int J Cancer 1997 0.87
24 Results of retroperitoneal laparoscopic radical nephrectomy. J Endourol 2001 0.86
25 Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia. Prostate 2000 0.86
26 Muscle precursor cell autografting in a murine model of urethral sphincter injury. BJU Int 2002 0.85
27 Extraperitoneal laparoscopic repair of ureteropelvic junction obstruction: initial experience in 15 cases. Urology 2000 0.85
28 Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2. Urol Res 2002 0.85
29 Carcinological risks and retroperitoneal laparoscopy. Eur Urol 2000 0.84
30 Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol 1985 0.83
31 Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas. Oncogene 1999 0.83
32 Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer. Br J Cancer 1995 0.83
33 Apoptotic conversion: evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis. Cancer Res 1999 0.83
34 Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas. Hum Pathol 1999 0.82
35 Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy. Int J Cancer 1999 0.82
36 Retroperitoneoscopic nephroureterectomy for renal pelvic tumors with a single iliac incision. J Urol 1999 0.82
37 [Prostatic adenocarcinoma revealed by disseminated intravascular coagulation and fibrinolysis]. Ann Urol (Paris) 2002 0.82
38 Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients. Urology 2000 0.81
39 Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies. Urol Res 1986 0.81
40 [Laparoscopic excision of para-aortic lymphatic metastasis of malignant pheochromocytoma]. Ann Urol (Paris) 2001 0.80
41 p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Br J Cancer 2001 0.80
42 Polyphenols purified from the Brazilian aroeira plant (Schinus terebinthifolius, Raddi) induce apoptotic and autophagic cell death of DU145 cells. Anticancer Res 2006 0.79
43 [Classification, favorable characteristics, prevention and treatment of adverse side-effects associated with Bacillus Calmette-Guerin in the treatment of superficial bladder cancer]. Ann Urol (Paris) 2002 0.79
44 Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer. World J Urol 1993 0.79
45 Consecutive use of hormonally defined serum-free media to establish highly differentiated human renal proximal tubule cells in primary culture. J Am Soc Nephrol 1995 0.78
46 Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 2000 0.78
47 Leukocyturia as a predictor of tolerance and efficacy of intravesical BCG maintenance therapy for superficial bladder cancer. Urology 2001 0.78
48 [Tissue engineering in urology]. Ann Urol (Paris) 2004 0.78
49 Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients. Eur Urol 2000 0.77
50 [Cancer of the prostate: influence of nutritional factors. Vitamins, antioxidants and trace elements]. Presse Med 2001 0.77
51 A comparison of direct and liposomal antibody conjugates of sulfonated aluminum phthalocyanines for selective photoimmunotherapy of human bladder carcinoma. Photochem Photobiol 1994 0.77
52 Assessment of penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. J Urol 2000 0.77
53 Fibroblast growth factors and their specific binding sites in normal urothelium and transitional cell carcinoma (TCC) of the human bladder. Cell Mol Biol (Noisy-le-grand) 1995 0.75
54 Biopsy-based diagnosis of prostate cancer in 1290 patients referred for prostate examination: results according to the PSA level, digital rectal examination and ultrasonography. Acta Chir Hung 1998 0.75
55 [Arterial reconstruction with detubulated aortic patch in simultaneous kidney-pancreas transplantation]. Ann Urol (Paris) 2002 0.75
56 [BCG therapy. Its role in the treatment of tumors of the bladder]. Ann Urol (Paris) 1995 0.75
57 [Aspergillosis located on polycystic kidney treated with retroperitoneal nephrectomy]. Ann Urol (Paris) 2001 0.75
58 Appendicular abscess presenting as an infiltrating bladder tumour. BJU Int 2002 0.75
59 [Pelvic lymphatic excision using laparoscopy. Its value in the staging of tumors of the bladder]. Ann Urol (Paris) 1993 0.75
60 [A procedure for bladder replacement using a low-pressure ileal reservoir]. Ann Urol (Paris) 1993 0.75
61 Pouch conservation during Studer enterocystoplasty in ileal nondetubularized segmental stenosis. J Urol 1999 0.75
62 [Natural history and prognostic factors of superficial tumors of the bladder]. Ann Urol (Paris) 1993 0.75
63 Complete solo laparoscopic radical prostatectomy: initial experience. Urology 2003 0.75
64 [Cancer of the prostate: influence of nutritional factors. General nutritional factors]. Presse Med 2001 0.75
65 Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guérin endovesical immunotherapy for superficial bladder tumors. Eur Urol 1990 0.75
66 [Evaluations of protein p53 overexpression in cancer of the bladder: prognostic value]. Chirurgie 1996 0.75
67 Evaluation of pancreas grafts in the Wistar rat after variable perfusion flow rates in two organ procurement procedures. Transplant Proc 1995 0.75
68 [Cystic cancer of the kidney]. Ann Urol (Paris) 1990 0.75
69 [The use of monoclonal antibodies in the evaluation of the aggressiveness of tumors of the bladder]. Ann Urol (Paris) 1993 0.75
70 [Place of prostatectomy and radiotherapy in the treatment of cancer of the prostate confined to the prostate gland (T0, T1, T2)]. Ann Urol (Paris) 1986 0.75
71 [Preventive treatment of superficial tumors of the bladder using intravesical BCG. Review]. Ann Urol (Paris) 1993 0.75
72 Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessment. Anal Cell Pathol 1994 0.75
73 [Surgical anatomy of the lymphatic drainage of the bladder]. Ann Urol (Paris) 1993 0.75
74 [Cancer of the prostate: influence of nutritional factors. A new nutritional approach]. Presse Med 2001 0.75
75 Fast magnetic resonance imaging in the evaluation of tumoral obstructions of the inferior vena cava. J Urol 1992 0.75
76 Use of three additional mid biopsies to improve local assessment of prostate cancer in patients with one positive sextant biopsy. Eur Urol 1998 0.75